2Suppliers
3Customers
3Debt Items
2Related Chains

Source-Backed Evidence Depth

IO Biotech, Inc. (IOBT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships
1Distinct source URLs
6High confidence
0.833Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

IO Biotech, Inc. Suppliers

TickerNameConfidenceEvidence
MSD-INTERNATIONAL-BUSINESS-GMBH MSD-INTERNATIONAL-BUSINESS-GMBH 92% MSDIB provided KEYTRUDA® to be used in the clinical trial free of charge
MSD-INTERNATIONAL-GMBH MSD-INTERNATIONAL-GMBH 92% MSDIG provided KEYTRUDA® to be used in the clinical trial free of charge

IO Biotech, Inc. Customers

TickerNameConfidenceEvidence
IOBTQ IOBTQ 72% Reciprocal relationship from IOBTQ graph: Reciprocal relationship from IOBT graph: Reciprocal relationship from IOBTQ graph: Reciprocal relationship from IOBT graph: age in misconduct or other improp…
IOBTQ IOBTQ 72% age in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading. We are exposed to the risk of fraud or other misconduct by our…
EMERGING-GROWTH-COMPANY EMERGING-GROWTH-COMPANY 62% ly expect that our cash and cash equivalents of $30.7 million as of September 30, 2025 will not be sufficient to fund our operating expenses and capital requirements for at least 12 months from the d…

IO Biotech, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IOBT-DEBT-10324 Warrants outstanding: -7259000 90% xbrl warrant detail from xbrl 2025-09-30.
IOBT-DEBT-10325 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
IOBT-DEBT Debt stack $18.1M 90% Market cache reports total debt of $18.1M.

IO Biotech, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for IO Biotech, Inc..

IO Biotech, Inc. Ownership

HolderNameConfidenceEvidence
IOBT-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 13 tracked holders.

IO Biotech, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IOBTQ IO Biotech, Inc. 100.00 1 ['customer']
NKTR Nektar Therapeutics 50.00 2
🔐
IOBT
Unlock IOBT Supply Chain Data
Verified relationships include:
MSD-INTERNATIONAL-BUSINESS-GMBHMSD-INTERNATIONAL-BUSINESS-GMBHSupplier92%
MSD-INTERNATIONAL-GMBHMSD-INTERNATIONAL-GMBHSupplier92%
IOBTQIOBTQCustomer72%
IOBTQIOBTQCustomer72%
+5 more relationships locked
Subscribe, View plans →